K-V Pharmaceutical Company (NYSE: KV-A)(NYSE: KV-B) and certain of its domestic subsidiaries today filed voluntary Chapter 11 petitions under the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE